Serum antibody fingerprinting of SARS-CoV-2 variants in infected and vaccinated subjects by label-free microarray biosensor.

Authors:
Carzaniga T; Casiraghi L; Nava G; Zanchetta G; Inzani T and 8 more

Journal:
Front Immunol

Publication Year: 2024

DOI:
10.3389/fimmu.2024.1323406

PMCID:
PMC10927789

PMID:
38476234

Journal Information

Journal Title: Front Immunol

Detailed journal information not available.

Publication Details

Subject Category: Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

Evidence found in paper:

"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work has received funding from Ministero dell’Università e della Ricerca through grants: CN00000041 “National Center for Gene Therapy and Drugs based on RNA Technology” (CUP G43C22001320007, PNRR MUR-M4C2-Investimento 1.4, funded by European Union—NextGenerationEU); FISR 2020 COVID, “VIAEREA” project No. FISR2020IP-04633; PRIN 2017, project No. 2017Z55KCW; “Erogazione liberale per le attività di ricerca sul Coronavirus”, No. LIBVT20COVID19SEPIS; and Fondazione “Romeo ed Enrica Invernizzi” No. LIBVT21BAND. LC and TI were supported by young scientist fellowships from the UNIMI GSA-IDEA project. The authors acknowledge support from the University of Milan through the APC initiative."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025